… richly pigmented tissues, leading to the first radiotracer N-(2-diethylaminoethyl)-4-iodobenzamide
(BZA), specifically designed to diagnose malignant melanoma (Michelot et al., 1991). …

… on the human eyes except in the case of ocular melanoma, whereas great uveal uptake
was … melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide) …

… approach for SPECT imaging of metastatic melanoma leading … Patients with cutaneous
melanomas will be recruited at the … -Ferrand and patients with uveal melanomas will be recruited …

… Interestingly, recent research has proposed that N-(2-diethylaminoethyl) rather than the
aromatic … Ga-TRAP(RGD) 3 showed high-contrast visualization of the M21 tumor. e Chemical …

… The higher sensitivity of PET and SPECT in many … The kidneys and bladder were visualized
in all animals, demonstrating … -[2-diethylamino-ethyl]4-iodobenzamide) (iodoBZA) labelled …

… in two melanoma patients for visualization of metastases … have been developed for melanoma
SPECT and PET imaging. … The N-(2-diethylaminoethyl)-4-iodobenzamide (BZA) was first …

… melanoma detection using SPECT (16–19). These probes were evaluated in B16 murine
melanoma… -DMFB to visualize LNs harboring metastatic malignant melanoma in mouse models…

… a murine model of melanoma after administration of N-(2-diethylaminoethyl)-4-iodobenzamide
( 125 I… metastasis in 87 patients with a history of cutaneous or ocular melanoma. While the …

… The tumor to background increases with time, and tumors could be clearly visualized starting
from 24 h post administration. Similar results were obtained in mice bearing LNCaP tumors. …

… B16 melanoma (6.75 %ID/g) and liver (6.04 %ID/g) at 1 h after intravenous injection [6]. The
first clinical trial of 123 IN-(2-diethylaminoethyl)4-Iodobenzamide ( … to ocular melanoma, eye …